Davidson Kempner Capital Management »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Davidson Kempner Capital Management

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Davidson Kempner Capital Management from 13F filings

Historical chart of Davidson Kempner Capital Management investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Davidson Kempner Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Davidson Kempner Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $46M 45M 1.01
2023-09-30 $47M 42M 1.12

More positions owned by Davidson Kempner Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Arko Corp (ARKO)
Kenvue (KVUE)
Joyy Note 1.375% 6/1 (Principal)
Pdd Holdings Note 12/0 (Principal)
Wayfair Note 3.250% 9/1 (Principal)
Vnet Group Note 2/0 (Principal)
Playa Hotels & Resorts Nv SHS (PLYA)
Metropcs Communications (TMUS)
Meta Platforms Cl A (META)
Amazon (AMZN)
Redfin Corp Note 0.500% 4/0 (Principal)
Linde SHS (LIN)
Angel Oak Mtg (AOMR)
Li Auto Note 0.250% 5/0 (Principal)

View all positions for Davidson Kempner Capital Management

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Wolverine Asset Management
Calamos Advisors
Braidwell
Highbridge Capital Management
Davidson Kempner Capital Management
Readystate Asset Management
Bank of America Corporation
Lazard Asset Management
Tenor Capital Management
D. E. Shaw & Co
Bank Of Montreal
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Steelhead Partners
Context Capital Management
Capstone Investment Advisors

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1